|
|
||||||||
Ann Thorac Surg 2000;70:1675-1678
© 2000 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, Saint Louis, Missouri, USA
b Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA
Address reprint requests to Dr Meyers, Department of Cardiothoracic Surgery, Washington University School of Medicine, 3108 Queeny Tower, One Barnes-Jewish Hospital Plaza, St. Louis, MO 63110-1013
e-mail: meyersb{at}msnotes.wustl.edu
Presented at the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31Feb 2, 2000.
| Abstract |
|---|
|
|
|---|
Methods. A retrospective review of patient records and computerized database was performed. Living patients were contacted to confirm their health and functional status.
Results. Patients included 13 men and 8 women with a mean age of 43 years. Sixteen patients were considered stable awaiting lung transplant, whereas 5 patients were unstable with acute graft failure after prior lung transplantation. Stable patients had been ventilated for a mean of 57 ± 46 days whereas unstable patients had been supported for 10 ± 9 days. Half of the patients required cardiopulmonary bypass support during the transplant, and there was no statistical difference in the frequency of CPB in stable and unstable patients (p = 0.61). Three hospital deaths included 0 of 16 of the stable patients and 3 of 5 of the unstable patients (p = 0.01). Long-term actuarial survival was significantly better in stable versus unstable patients (p = 0.02), with 5-year survival 40% for stable patients and 0% for unstable patients.
Conclusions. Lung transplantation can be successfully conducted in stable patients who have become ventilator dependent after listing for transplantation. Acute retransplantation for early lung dysfunction is high risk and has produced poor long-term results.
| Introduction |
|---|
|
|
|---|
| Patients and methods |
|---|
|
|
|---|
Statistical methods
All normally distributed continuous data (FEV1, age, etc) are expressed as mean ± standard deviation. Two group comparisons of normally distributed, continuous data are made using the unpaired t test. Nonnormally distributed data (ie, postoperative hospital stay) are expressed as median and interquartile range. The interquartile range (IQR) describes the limits that contain the subset of values between the 25th and 75th percentile. Two group comparisons in these data sets are made with the Mann-Whitney U statistic. Survival estimates were calculated with the Kaplan-Meier method. Comparison of survival of different groups of patients is done with the Mantel-Haenszel log rank test. Tabular data are compared using Fishers exact test. A p value less than 0.05 was considered statistically significant.
Recipient selection
The selection of recipients for lung transplant has become a relatively standard process, and selection criteria have been described in previous publications [24]. Briefly, patients are selected when they have disabling lung disease with a limited prognosis and no other systemic illness that would complicate, or be complicated by, lung transplantation and immunosuppressive therapy.
Preoperative treatment
Once patients are listed for lung transplantation, efforts are made to optimize their medical care to enhance survival and function while on the organ waiting list. For all patients, this involves enrollment and active participation in pulmonary rehabilitation. Adjustment of medications may include weaning of steroids to minimize the complications of corticosteroids during the time spent on the waiting list for donor lungs. Preoperative therapy ranges from ensuring continued compliance with pulmonary rehabilitation to acute management, including intubation and intensive care when deterioration occurs during the waiting period. Although patients will generally not be listed if they are intubated, patients who decline after listing for transplant are still considered if their general health is otherwise compatible with postoperative recovery from a transplant. Many of the patients in this report continued to be involved in physical therapy and pulmonary rehabilitation despite their need for mechanical ventilation.
Donor selection
The criteria that are used to evaluate lung donors are well established. Our donor lung selection criteria and our operative techniques for lung procurement have recently been reviewed [5]. We routinely classify a donor as ideal or marginal based on criteria published previously [6]. Review of donor classification in this article is pertinent to assess how the ventilated status of the proposed recipient affected the subjective decisions surrounding donor selection. Specifically, we wanted to test the hypothesis that more marginal donors were accepted in light of proposed recipients ventilator dependency.
Operative techniques and postoperative care
Our current operative technique has been described in previous publications [7]. Early postoperative care occurs in the intensive care unit with mechanical ventilation and invasive cardiac monitoring. We routinely extubate patients as soon as standard weaning criteria are met. Flexible bronchoscopy is performed at the time of extubation and again 7 to 10 days after transplantation. Immunosuppressive therapy consists initially of cyclosporin, corticosteroids, and azathioprine, with the addition of antithymocyte globulin during the first several postoperative days [3]. Patients who had tracheostomies preoperatively had the tracheostomy replaced at the end of the case, as their likelihood for early extubation is believed to be lower than that for nonventilated patients.
| Results |
|---|
|
|
|---|
|
|
Three patients, all of them recipients of acute retransplant operations for early graft dysfunction, were considered operative deaths. Causes of death included a massive bleeding episode in 1 patient, fungal sepsis in 1 patient, and multisystem organ dysfunction in 1 patient.
In the first case, a 47-year-old man had a bilateral lung transplant for
1-emphysema. He developed severe proximal graft bronchus ischemia and necrosis with dehiscence. On postoperative day 6 a bilateral retransplantion was performed using cardiopulmonary bypass. Renal and hepatic dysfunction developed postoperatively and dialysis was instituted. Pseudomonas was isolated from tracheobronchial secretions and Candida was isolated from all sites. On postoperative day 11 after the retransplant he suffered a massive bleed into the chest and arrested.
A 57-year-old woman had a bilateral lung transplant for
1-emphysema. Severe reperfusion edema and hypoxemia in the first lung led to urgent CPB while implanting the second lung. Severe bilateral reperfusion injury led to prolonged mechanical ventilation. An air leak developed on the right and quickly became "massive," thus complicating ventilation of the stiff lungs. A dehiscence was noted, and concerns over reperfusion injury, viral pneumonitis, and hyperacute rejection led to retransplantation on postoperative day 8. Postoperative complications included duodenal perforation, mental status deterioration, repeat bronchial dehiscence, and fungal wound infection. She died 45 days after the retransplantation from Aspergillus sepsis due to foci of the fungus in lung abscesses, empyema, endocarditis, and peritonitis.
A 41-year-old man had a right single lung transplant for pulmonary fibrosis. Immediate, severe lung dysfunction led to extracorporeal membrane oxygenation support. Failure to improve more than 48 hours led to a decision to retransplant using a marginal but acceptable donor. His postoperative course after retransplantation was stormy with poor allograft function, continued extracorporeal membrane oxygenation support, bleeding, renal failure, and hepatic dysfunction. On postoperative day 6 after the second transplant, support was withdrawn and he died.
Some details regarding the postoperative hospital stay are recorded in Table 3. The postoperative length of intubation, intensive care unit stay, and overall hospital stay were significantly longer for the stable ventilated patients as compared to nonventilated patients. These analyses were not performed for the unstable patients, as 3 of the 5 such patients died postoperatively.
|
|
| Comment |
|---|
|
|
|---|
Lung transplantation for patients in stable respiratory failure is more promising. In our 16 stable ventilated patients there were no postoperative hospital deaths and a long-term survival that is not statistically different from that of the general population of our programs transplant recipients. These patients do seem to be more prone to prolonged intubation and hospitalization after the transplant, but the results indicate that these problems are surmountable and that long-term results are acceptable.
Our practice continues to be the same as described in this article: we will consider transplantation in stable patients who have declined on the waiting list, but we are skeptical of, and generally discourage, transplantation for acute lung dysfuction regardless of the etiology.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
A T Jones, R M Du Bois, and A U Wells The pulmonary physician in critical care * Illustrative case 2: Interstitial lung disease Thorax, April 1, 2003; 58(4): 361 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Zwischenberger, D. Wang, S. D. Lick, D. J. Deyo, S. K. Alpard, and S. D. Chambers The paracorporeal artificial lung improves 5-day outcomes from lethal smoke/burn-induced acute respiratory distress syndrome in sheep Ann. Thorac. Surg., October 1, 2002; 74(4): 1011 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Lick, J. B. Zwischenberger, D. Wang, D. J. Deyo, S. K. Alpard, and S. D. Chambers Improved right heart function with a compliant inflow artificial lung in series with the pulmonary circulation Ann. Thorac. Surg., September 1, 2001; 72(3): 899 - 904. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |